| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30040827 | HIV | ENSG00000005844.19 | protein_coding | ITGAL | No | No | 3683 | P20701 |
| TVIS30040828 | HIV | ENSG00000005844.19 | protein_coding | ITGAL | No | No | 3683 | P20701 |
| TVIS20007386 | HPV | ENSG00000005844.19 | protein_coding | ITGAL | No | No | 3683 | P20701 |
| TVIS20013342 | HPV | ENSG00000005844.19 | protein_coding | ITGAL | No | No | 3683 | P20701 |
| TVIS44008681 | HTLV-1 | ENSG00000005844.19 | protein_coding | ITGAL | No | No | 3683 | P20701 |
| TVIS44051217 | HTLV-1 | ENSG00000005844.19 | protein_coding | ITGAL | No | No | 3683 | P20701 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ITGAL |
|---|---|
| DrugBank ID | DB00095 |
| Drug Name | Efalizumab |
| Target ID | BE0000516 |
| UniProt ID | P20701 |
| Regulation Type | antibody |
| PubMed IDs | 19170413; 17053736; 11752352; 15799683 |
| Citations | Frampton JE, Plosker GL: Efalizumab: a review of its use in the management of chronic moderate-to-severe plaque psoriasis. Am J Clin Dermatol. 2009;10(1):51-72. doi: 10.2165/0128071-200910010-00009.@@Descamps V: [Efalizumab]. Ann Dermatol Venereol. 2006 Aug-Sep;133(8-9 Pt 1):666-78.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Wellington K, Perry CM: Efalizumab. Am J Clin Dermatol. 2005;6(2):113-8; discussion 119-20. doi: 10.2165/00128071-200506020-00006. |
| Groups | Approved; Investigational; Withdrawn |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA164748817 |
| ChEMBL | CHEMBL1201575 |
